Liu, C., Shen, H., Li, H., Wang, N., He, S., Ye, G., & Cong, W. (2024). An evodiamine derivative inhibits osteoclast differentiation and protects against OVX‐induced bone loss in mice. Clinical & Experimental Pharmacology & Physiology, 51(12), 1. https://doi.org/10.1111/1440-1681.13926
Chicago Style (17th ed.) CitationLiu, Chao, Huaxing Shen, Huang Li, Nan Wang, Shipeng He, Guangming Ye, and Wei Cong. "An Evodiamine Derivative Inhibits Osteoclast Differentiation and Protects Against OVX‐induced Bone Loss in Mice." Clinical & Experimental Pharmacology & Physiology 51, no. 12 (2024): 1. https://doi.org/10.1111/1440-1681.13926.
MLA (9th ed.) CitationLiu, Chao, et al. "An Evodiamine Derivative Inhibits Osteoclast Differentiation and Protects Against OVX‐induced Bone Loss in Mice." Clinical & Experimental Pharmacology & Physiology, vol. 51, no. 12, 2024, p. 1, https://doi.org/10.1111/1440-1681.13926.